Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale L Barnard

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Antiviral Research|February 5, 2009
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assaysJason P Roth, Joseph K-K Li, Donald F Smee, et al.
Antiviral Chemistry & Chemotherapy|December 21, 2006
Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV)Chung K Chu, Srinivas Gadthula, Xin Chen, et al.
Vaccine|July 19, 2011
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoVYe V Liu, Michael J Massare, Dale L Barnard, et al.
Vaccine|July 21, 2007
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in miceMary C Hu, Taff Jones, Richard T Kenney, et al.
Archives of Virology|December 7, 2013
In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virusE Bart Tarbet, Almut H Vollmer, Brett L Hurst, et al.
Heliyon|July 13, 2022
Examining the interactions of Galahad™ compound with viruses to develop a novel inactivated influenza A virus vaccineDale L Barnard, David M Belnap, Parastoo Azadi, et al.
Antiviral Chemistry & Chemotherapy|December 1, 2007
Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense virusesPeriyasamy Selvam, Paulchamy Vijayalakshimi, Donald F Smee, et al.
Antiviral Research|August 27, 2011
Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virusJustin G Julander, Joe Hagloch, Scott Latimer, et al.
Antiviral Chemistry & Chemotherapy|December 14, 2012
Antiviral agents derived from novel 1-adamantyl singlet nitrenesAndreas J Kesel, Hans-Christoph Weiss, Andreas Schönleber, et al.
Antiviral Chemistry & Chemotherapy|April 13, 2004
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidineDale L Barnard, Valerie D Hubbard, Jared Burton, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Antiviral Research|February 5, 2009
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assaysJason P Roth, Joseph K-K Li, Donald F Smee, et al.
Antiviral Chemistry & Chemotherapy|December 21, 2006
Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV)Chung K Chu, Srinivas Gadthula, Xin Chen, et al.
Vaccine|July 19, 2011
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoVYe V Liu, Michael J Massare, Dale L Barnard, et al.
Vaccine|July 21, 2007
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in miceMary C Hu, Taff Jones, Richard T Kenney, et al.
Archives of Virology|December 7, 2013
In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virusE Bart Tarbet, Almut H Vollmer, Brett L Hurst, et al.
Heliyon|July 13, 2022
Examining the interactions of Galahad™ compound with viruses to develop a novel inactivated influenza A virus vaccineDale L Barnard, David M Belnap, Parastoo Azadi, et al.
Antiviral Chemistry & Chemotherapy|December 1, 2007
Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense virusesPeriyasamy Selvam, Paulchamy Vijayalakshimi, Donald F Smee, et al.
Antiviral Research|August 27, 2011
Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virusJustin G Julander, Joe Hagloch, Scott Latimer, et al.
Antiviral Chemistry & Chemotherapy|December 14, 2012
Antiviral agents derived from novel 1-adamantyl singlet nitrenesAndreas J Kesel, Hans-Christoph Weiss, Andreas Schönleber, et al.
Antiviral Chemistry & Chemotherapy|April 13, 2004
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidineDale L Barnard, Valerie D Hubbard, Jared Burton, et al.
Pageof 6